not tagged
not tagged
['lymsm']
zamto-cel bite (cd19xcd20 41bb car) #17icml
- 14 days vein to vein time, no bridging allowed
- 28 pts (all received car)
- 1 hlh, no gr3 crs, 2 gr3 icans, 9 deaths
- orr 82% (cr 55%)
- 3 pts did have cd19 and/or cd20 loss at progression
short manufacturing promising. #lymsm 
Lymphoma doc & patient-reported outcomes researcher in #lymsm and #mmsm @CUHematology. Founder of https://t.co/kN6qeGFEox, @inTrainingDoc & @inHouseMag. 🏳️‍🌈